about kinex

Kinex Pharmaceuticals - Buffalo NY Biotechnology Company

Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.

Our Company >>

clinical trials

Kinex Pharmaceuticals Clinical Trials

Kinex plans to enter multiple Phase 2 studies with KX01 in 2013. Clinical studies will include Acute Myeloid Leukemia (AML), and Chronic Myeloid Leukemia (CML).

Clinical Trials >>

News/Events

Dr. Allen Barnett Receives Distinguished Alumni Award from the University at Buffalo Friday, March 28th, 2014

Kinex is pleased to congratulate Dr. Allen Barnett, Kinex Founder and President Emeritus on receiving a Distinguished Alumni Award from the University

Kinex and Zenith Technology to Initiate Clinical Studies of an Oral Form of Paclitaxel (Oraxol) in New Zealand Wednesday, March 19th, 2014

Kinex Pharmaceuticals announced today to having received regulatory and ethics approvals to initiate the first clinical study of an oral form of

News/Events >>